Covered recipient · General Payments record
MATTHEW P OLIVO
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,201.58
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $434.35 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Galderma Laboratories, L.P. | $151.70 | 5 |
| Janssen Biotech, Inc. | $136.24 | 2 |
| UCB, Inc. | $101.30 | 1 |
| Kerecis Limited | $26.56 | 1 |
| ABBVIE INC. | $18.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.55 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105152577 | CMS |
| Galderma Laboratories, L.P. | $17.98 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145319773 | CMS |
| Galderma Laboratories, L.P. | $124.99 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145319775 | CMS |
| Galderma Laboratories, L.P. | $2.28 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145319777 | CMS |
| Galderma Laboratories, L.P. | $2.44 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145319779 | CMS |
| Galderma Laboratories, L.P. | $4.01 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145319781 | CMS |
| Janssen Biotech, Inc. | $124.25 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078381594 | CMS |
| Janssen Biotech, Inc. | $11.99 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078381610 | CMS |
| Kerecis Limited | $26.56 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120103251 | CMS |
| UCB, Inc. | $101.30 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143198539 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.